As Europe’s cannabis market accelerates, one thing is becoming increasingly clear: Germany is no longer just a policy experiment. It’s the engine.
From medical cannabis growth to the rollout of social clubs, seed and clone commerce, and pilot programs for regulated adult-use supply chains, Germany is now shaping the pace and structure of Europe’s cannabis economy. And this April, that momentum converges at International Cannabis Business Conference (ICBC) Berlin 2026, returning April 13–15 at the Estrel Berlin Hotel.
High Times is a media partner of ICBC Berlin 2026.
ICBC Berlin has established itself as Europe’s largest cannabis-focused B2B event, drawing operators, investors, policymakers, suppliers, and infrastructure providers from across the continent and beyond. The conference consistently attracts:
But the relevance of the 2026 edition goes beyond scale.
Germany’s cannabis market is entering a decisive phase. Medical patient enrollment has surged following the removal of cannabis from the country’s Narcotics List. Commercial trade in seeds and clones is now legal nationwide. Member-based social cannabis clubs are expected to launch soon. Pilot commerce models are advancing. And further regulatory clarity around CBD is anticipated this year.
For companies operating anywhere in the European cannabis ecosystem — or looking to enter it — Germany has become unavoidable.
ICBC Berlin is built around participation, not passive attendance. The event brings together licensed pharmacies, social clubs, grow shops, manufacturers, genetics providers, technology firms, compliance specialists, and international brands looking to establish or expand their European footprint.
To facilitate real business, ICBC offers free passes to select buyer categories, including German social clubs, cannabis pharmacies, and European grow shops — ensuring that exhibitors aren’t just networking, but meeting decision-makers.
What might take years of outreach and travel can often be accomplished in days under one roof.
With interest building ahead of April, ICBC has announced that ticket prices will increase by €150 on January 28. For operators planning to attend, exhibit, or sponsor, the current pricing window represents an opportunity to secure access before costs rise.
While the full 2026 program has not yet been announced, ICBC Berlin’s value has historically rested less on hype and more on proximity — proximity to capital, to partners, to regulators, and to the people actively building Europe’s cannabis infrastructure.
As Germany continues to define the next phase of legalization and commerce, ICBC Berlin remains one of the few places where the continent’s cannabis business actually comes together.
High Times is a media partner of ICBC Berlin 2026.
<p>The post Europe’s Cannabis Industry Is Growing Fast. ICBC Berlin Is Where It Connects first appeared on High Times.</p>
A new collaboration brings together iconic functional glass, carefully selected cannabis genetics and a mission…
This interview by Micah Johnson originally appeared in High Times Local, produced under license by…
Congress's watchdog confirmed the DEA has no complete written procedures for drug scheduling. Learn why…
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…
The DEA has opened a new registration process for state-licensed medical cannabis manufacturers, distributors and…
This November gathering will bring psychedelic education into conversation with music, visual art, comedy, philosophy,…